Smoking Related Diseases: The Central Role of Monoamine Oxidase
2011

Smoking and Monoamine Oxidase: Understanding the Connection

Sample size: 115 publication 10 minutes Evidence: moderate

Author Information

Author(s): Rendu Francine, Peoc’h Katell, Berlin Ivan, Thomas Daniel, Launay Jean-Marie

Primary Institution: Université Pierre et Marie Curie

Hypothesis

Does smoking induce long-lasting changes in monoamine oxidase activity and its epigenetic regulation?

Conclusion

Smoking leads to a persistent increase in monoamine oxidase-B levels, which may serve as a biomarker for smoking-related diseases.

Supporting Evidence

  • Smoking is a major risk factor for cardiovascular diseases and cancer.
  • Monoamine oxidase activity is decreased in smokers.
  • High levels of monoamine oxidase-B persist for over ten years after quitting smoking.

Takeaway

Smoking changes how our body processes certain chemicals, which can lead to health problems even after quitting.

Methodology

The study measured monoamine oxidase levels and activity in blood platelets of smokers, former smokers, and non-smokers.

Potential Biases

Potential biases in participant selection and self-reported smoking status.

Limitations

The study's findings may not apply to women or other populations without further research.

Participant Demographics

The study involved 115 men, including smokers, former smokers, and non-smokers.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.3390/ijerph8010136

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication